State SC
Clinical Trials in South Carolina
Recruiting clinical trials with at least one study location in South Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in South Carolina
NCT05256940 N/A
Recruiting
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk...
Condition
Suicide, Attempted
Enrollment
470 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT04620239 Phase 3
Recruiting
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTE...
Condition
Transitional Cell Cancer of Renal Pelvis and Ureter
Enrollment
100 pts
Location
United States, France, Germany
Sponsor
Steba Biotech S.A.
NCT06856577 Phase 3
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants ...
Condition
Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment
284 pts
Location
United States
Sponsor
Adverum Biotechnologies, Inc.
NCT05757102 Phase 3
Recruiting
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/V...
Condition
Asthma
Enrollment
292 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT07193511 Phase 1, Phase 2
Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Pati...
Condition
Solid Tumor Cancer
Enrollment
355 pts
Location
United States
Sponsor
Avenzo Therapeutics, Inc.
NCT06679985 Phase 2
Recruiting
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Part...
Condition
Hepatocellular Carcinoma
Enrollment
72 pts
Location
United States, Australia, Canada
Sponsor
Coherus Oncology, Inc.
NCT04903028 N/A
Recruiting
RTMS Targets Neural Circuits for Smoking Cessation
Condition
Tobacco Use
Enrollment
64 pts
Location
United States
Sponsor
Medical University of South Ca
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06345690 N/A
Recruiting
VIA Disc NP Registry 3.0
Condition
Discogenic Pain
Enrollment
500 pts
Location
United States
Sponsor
VIVEX Biologics, Inc.
NCT06121297 Phase 1, Phase 2
Recruiting
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of C...
Condition
Systemic Lupus Erythematosus
Enrollment
28 pts
Location
United States, Canada, Spain
Sponsor
Cabaletta Bio
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06807268 Phase 3
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years o...
Condition
Eczema
Enrollment
150 pts
Location
United States, China, Germany
Sponsor
Pfizer
NCT06225596 Phase 2, Phase 3
Recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial ...
Condition
Metastatic Urothelial Cancer
Enrollment
956 pts
Location
United States, Argentina, Australia
Sponsor
BicycleTx Limited
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT07016477 N/A
Recruiting
Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT...
Condition
Coronary Artery Disease
Enrollment
1,000 pts
Location
United States, Germany, Hungary
Sponsor
Semmelweis University
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
NCT07215312 Phase 2
Recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated Wit...
Condition
Diabetes Mellitus, Type 2
Enrollment
100 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
NCT04592445 N/A
Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having H...
Condition
Heart Failure With Preserved Ejection Fraction (HFpEF
Enrollment
150 pts
Location
United States
Sponsor
Axon Therapies, Inc.
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr